Two Sigma Advisers’s Histogen Inc. Common Stock HSTO Stock Holding History

Two Sigma Advisers’s Portfolio HSTO Stock Details HSTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-730	Closed	-$4K	–	2985
2022 Q1	$4K	Sell	730 -720	-50%	-$3.65K	﹤0.01%	2711
2021 Q4	$10K	Buy	1,450 +780	+116%	+$8.92K	﹤0.01%	2575
2021 Q3	$10K	Buy	+670	New	+$11.3K	﹤0.01%	2414

Other funds holding HSTO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Two Sigma Advisers's HSTO Position: Q2 2022 in Review

Two Sigma Advisers sold out of Histogen Inc. Common Stock (HSTO) in Q2 2022, closing a stake of 730 shares — an estimated $4K sold.

Two Sigma Advisers first reported a position in HSTO in Q3 2021 and held it in 3 quarters. The position peaked at $10K in Q4 2021. 10 funds tracked by Wall St. Rank hold HSTO as of Q2 2022.

Two Sigma Advisers reported no remaining Histogen Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Two Sigma Advisers sold 730 Histogen Inc. Common Stock shares in Q2 2022, an estimated $4K.
Two Sigma Advisers first reported a position in Histogen Inc. Common Stock in Q3 2021 and held it in 3 quarters.
Two Sigma Advisers's Histogen Inc. Common Stock position peaked at $10K in Q4 2021.
10 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2022.

Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.